Pharma Mar SA's market cap is currently €1.82B. The company's EPS TTM is €0.035; its P/E ratio is 2,872.52; and it has a dividend yield of 0.66%. Pharma Mar SA is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is €-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	€ 158.15M	€ 196.34M	€ 229.83M	€ 269.96M	€ 85.82M
Gross Profit	€ 148.54M	€ 182.70M	€ 213.39M	€ 256.24M	€ 80.59M
Operating Income	€ -3.83M	€ 44.07M	€ 92.45M	€ 155.94M	€ -17.48M
EBITDA	€ 4.55M	€ 52.07M	€ 104.08M	€ 155.94M	€ -11.71M
Net Income	€ 1.14M	€ 49.36M	€ 92.86M	€ 137.26M	€ -9.18M
Balance Sheet
Cash & Short-Term Investments	€ 162.56M	€ 182.42M	€ 201.88M	€ 195.52M	€ 20.89M
Total Assets	€ 340.52M	€ 393.26M	€ 368.39M	€ 330.26M	€ 124.70M
Total Debt	€ 43.67M	€ 42.63M	€ 49.33M	€ 56.66M	€ 86.11M
Net Debt	€ -16.36M	€ -107.18M	€ -64.02M	€ -39.55M	€ 68.48M
Total Liabilities	€ 147.08M	€ 170.30M	€ 190.47M	€ 227.54M	€ 117.25M
Stockholders' Equity	€ 193.44M	€ 222.96M	€ 177.92M	€ 102.72M	€ 11.37M
Cash Flow
Free Cash Flow	€ -29.40M	€ 29.47M	€ 17.87M	€ 275.94M	€ -30.05M
Operating Cash Flow	€ -13.45M	€ 38.32M	€ 25.68M	€ 278.94M	€ -26.14M
Investing Cash Flow	€ -43.05M	€ 10.88M	€ 18.47M	€ -119.01M	€ 32.07M
Financing Cash Flow	€ -32.14M	€ -13.37M	€ -27.41M	€ -73.82M	€ -11.04M

Currency in EUR

Pharma Mar SA Earnings and Revenue History

Income Statement >

Pharma Mar SA Debt to Assets

Balance Sheet >

Pharma Mar SA Cash Flow

Cash Flow >

Pharma Mar SA Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing